You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 4, Issue 10

October 2011 - 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Review
  • Open Access
11 Citations
8,645 Views
19 Pages

Lipothioureas as Lipids for Gene Transfection: A Review

  • Marie Breton,
  • Jeanne Leblond,
  • Isabelle Tranchant,
  • Daniel Scherman,
  • Michel Bessodes,
  • Jean Herscovici and
  • Nathalie Mignet

24 October 2011

Non-viral gene therapy requires innovative strategies to achieve higher transfection efficacy. A few years ago, our group proposed bioinspired lipids whoseinteraction with DNA was not based on ionic interactions, but on hydrogen bonds. We thusdevelop...

  • Review
  • Open Access
60 Citations
15,760 Views
26 Pages

Stem Cell Therapy: A New Treatment for Burns?

  • Anna Arno,
  • Alexandra H. Smith,
  • Patrick H. Blit,
  • Mohammed Al Shehab,
  • Gerd G. Gauglitz and
  • Marc G. Jeschke

21 October 2011

Stem cell therapy has emerged as a promising new approach in almost every medicine specialty. This vast, heterogeneous family of cells are now both naturally (embryonic and adult stem cells) or artificially obtained (induced pluripotent stem cells or...

  • Review
  • Open Access
2 Citations
6,704 Views
13 Pages

Neural Changes Developed during the Extinction of Cocaine Self-Administration Behavior

  • Alejandro Higuera-Matas,
  • Miguel Miguens,
  • Nuria del Olmo,
  • Carmen García-Lecumberri and
  • Emilio Ambrosio

13 October 2011

The high rate of recidivism in cocaine addiction after prolonged periods of abstinence poses a significant problem for the effective treatment of this condition. Moreover, the neurobiological basis of this relapse phenomenon remains poorly understood...

  • Review
  • Open Access
14 Citations
11,686 Views
27 Pages

Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy

  • Sanath R. Wijerathna,
  • Md. Faiz Ahmad,
  • Hai Xu,
  • James W. Fairman,
  • Andrew Zhang,
  • Prem Singh Kaushal,
  • Qun Wan,
  • Jianying Kiser and
  • Chris G. Dealwis

13 October 2011

Ribonucleotide reductase (RR) is a crucial enzyme in de novo DNA synthesis, where it catalyses the rate determining step of dNTP synthesis. RRs consist of a large subunit called RR1 (α), that contains two allosteric sites and one catalytic site, and...

  • Review
  • Open Access
61 Citations
18,947 Views
20 Pages

10 October 2011

Pelargonium species contribute significantly to the health care of a large population in the Southern African region, as part of a long-standing medical system intimately linked to traditional healing practices. Most notably, extracts of the roots of...

  • Correction
  • Open Access
5,370 Views
2 Pages

30 September 2011

In the published version “Paladini et al. reported that aliskiren 300 mg provided a sustained BP-lowering effect beyond the 24-h dosing interval, with a significantly smaller loss of BP-lowering effect in the 24-48 h period after dose than irbesartan...

  • Article
  • Open Access
6 Citations
7,114 Views
12 Pages

26 September 2011

Cross-linked nanoassemblies (CNAs) with a degradable core were prepared for sustained release of 17-N-allylamino-17-demethoxygeldanamycin (17-AAG), a potent inhibitor of heat shock protein 90 (HSP90). The particle size of CNAs ranged between 100 and...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247